MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about outcome of board meeting

13 Feb 2020 Evaluate

Jagsonpal Pharmaceuticals has informed that the Board of Directors of the Company at their meeting held today, the13th February, 2020), approved and taken on record Un-Audited Financial Results of the Company for the Quarter and nine months ended 31st December, 2019; and Limited Review Report for the Quarter and Nine Months ended 31st December 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..